Skip to main content
Top

Interrogating the Impact of the Intestinal Microbiome on Transplant and Cellular Therapies

A session focusing on the emerging research investigating the host–gut microbiome axis in the context of response to stem cell transplantation and CAR T-cell therapy. Watch the presentations by Prof. Florent Malard, Dr. Lawrence David, and Dr. Tessa Andermann, and the audience Q&A.

Are you up to date on targeted therapies for relapsed/refractory AML? 

Join Prof. Amer Zeidan and his expert guests to hear about innovations in molecular testing, emerging therapies, and IDH-targeted treatments, and get practical advice for improving your patient care.

Supported by: independent educational grant from Rigel

Find out more
Image Credits
Interrogating the Impact of the Intestinal Microbiome on Transplant and Cellular Therapies